{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:40:04Z","timestamp":1746344404094,"version":"3.40.4"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>An allergic transfusion reaction is a common side effect of transfusions of red blood cells. Using washed red blood cells is the most effective method for preventing such a reaction. However, the availability of other washed transfusion components, including platelets, is limited.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 69-year-old patient with acute myeloid leukemia progressed from myelodysplastic syndrome and was treated with azacitidine. She experienced a minor reaction to platelet transfusion that initially responded to the administration of corticosteroids and antihistamines. However, she worsened even after subsequent preventive treatments and was referred to the emergency department due to anaphylaxis. The patient developed hypotension, chest pain, and dyspnea 10 minutes after the initiation of platelet transfusion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>She was diagnosed with platelet-induced anaphylaxis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>In an attempt to prevent anaphylaxis, 150\u200amg of omalizumab was prescribed 1\u200aweek prior to transfusion. However, she experienced anaphylaxis again and was administered intramuscular epinephrine. For the following transfusion, we treated her with a 300\u200amg dose of omalizumab 24\u200ahours before the transfusion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>She tolerated well and continued to receive further chemotherapy and platelet transfusion with premedication.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case suggests that omalizumab is a good candidate for the management of severe allergic transfusion reactions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027724","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T20:39:33Z","timestamp":1639082373000},"page":"e27724","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Successful management of severe allergic reactions to platelet transfusion with omalizumab"],"prefix":"10.1097","volume":"100","author":[{"given":"Yeonjoo","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, The Catholic University of Korea, St. Mary Incheon Hospital, Incheon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ja Min","family":"Byun","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Seoul National University Hospital, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inho","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Seoul National University Hospital, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hyun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Hwan","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Sil","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Suk","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, Seoul National University Boramae Medical Center, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5646-8054","authenticated-orcid":false,"given":"Hyunkyung","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1537-2995.1999.39399219278.x","article-title":"A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets","volume":"39","author":"Heddle","year":"1999","journal-title":"Transfusion"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1537-2995.2012.03892.x","article-title":"Scratching the surface of allergic transfusion reactions","volume":"53","author":"Savage","year":"2013","journal-title":"Transfusion"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1046\/j.1537-2995.2002.00117.x","article-title":"Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies","volume":"42","author":"Shimada","year":"2002","journal-title":"Transfusion"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000151350","article-title":"Reactions induced by platelet transfusions","volume":"35","author":"Kiefel","year":"2008","journal-title":"Transfus Med Hemother"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/S0140-6736(15)01313-6","article-title":"Transfusion reactions: prevention, diagnosis, and treatment","volume":"388","author":"Delaney","year":"2016","journal-title":"Lancet"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11882-010-0173-4","article-title":"Omalizumab: anti-IgE therapy in allergy","volume":"11","author":"Kopp","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/trf.15735","article-title":"Successful prevention of severe allergic transfusion reactions with omalizumab","volume":"60","author":"Shi","year":"2020","journal-title":"Transfusion"},{"issue":"(suppl 1)","key":"R9-20250504","first-page":"65s","article-title":"Adverse effects of plasma transfusion","volume":"52","author":"Pandey","year":"2012","journal-title":"Transfusion"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1537-2995.2010.03008.x","article-title":"Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction","volume":"51","author":"Tobian","year":"2011","journal-title":"Transfusion"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jaci.2006.04.005","article-title":"Anti-IgE as a mast cell-stabilizing therapeutic agent","volume":"117","author":"Chang","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11882-012-0316-x","article-title":"Use of omalizumab in the treatment of food allergy and anaphylaxis","volume":"13","author":"Lieberman","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.anai.2012.02.021","article-title":"Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab","volume":"108","author":"Bell","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2340\/00015555-1687","article-title":"Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis","volume":"94","author":"Kibsgaard","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jaip.2013.01.011","article-title":"Reassessment of omalizumab-dosing strategies and pharmacodynamics in inner-city children and adolescents","volume":"1","author":"Sorkness","year":"2013","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:02:51Z","timestamp":1746342171000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027724"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":14,"journal-issue":{"issue":"44","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027724","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"2021-08-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}